SQZ Biotechnologies Company (SQZB)
OTCMKTS: SQZB · Delayed Price · USD
0.0370
0.00 (0.00%)
Jul 19, 2024, 2:51 PM EDT - Market closed
SQZB Employees
SQZ Biotechnologies Company had 53 employees as of December 31, 2022. The number of employees decreased by 63 or -54.31% compared to the previous year.
Employees
53
Change (1Y)
-63
Growth (1Y)
-54.31%
Revenue / Employee
$351,132
Profits / Employee
-$1,436,094
Market Cap
1.09M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 53 | -63 | -54.31% |
| Dec 31, 2021 | 116 | 18 | 18.37% |
| Dec 31, 2020 | 98 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
| Danaher | 63,000 |
SQZB News
- 5 months ago - STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company - Business Wire
- 5 months ago - Asset Sale and Plan of Liquidation and Dissolution Approved by SQZB Shareholders - Business Wire
- 9 months ago - SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates - Business Wire
- 9 months ago - SQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual Meeting - Business Wire
- 1 year ago - SQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio Updates - Business Wire
- 1 year ago - SQZ Biotechnologies Provides Update on Collaboration with Roche - Business Wire
- 1 year ago - NYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ) - Business Wire
- 1 year ago - SQZ Biotechnologies to Consolidate Shares with 1-for-10 Reverse Stock Split - Business Wire